Those patients with more severe depression tend to have decreased improvements with lumbar surgery. No studies have investigated the impact of pretreatment psychosocial factors (e.g., depression) on posttreatment outcomes following conservative treatment. In the present study we assessed the impact of pretreatment depression on outcomes following conservative management for LSS. Our hypothesis was that similar to predictors of outcome following surgery, pretreatment depression would be associated with worsened quality of life (QOL) outcomes following medical therapy for LSS.
methods

Study Sample
A retrospective study of all patients in whom LSS was diagnosed at a single tertiary-care institution between September 2010 and March 2013 and who received nonsurgical management was performed. Nonsurgical management was based on the discretion of the individual medical provider but typically consisted of "usual care," 30 which includes physical therapy, administration of NSAIDs, and membrane-stabilizing agents. The extent of participation with physical therapy or medication treatment and other nonsurgical treatment was not used in the inclusion and exclusion criteria.
Patient data were extracted from the electronic medical records based on the inclusion and exclusion criteria. Inclusion was based on age older than 45 years and a diagnosis of LSS, which would be made based on criteria such as gluteal and/or lower-extremity pain and/or fatigue with or without back pain; symptoms aggravated by upright exercise such as walking or positionally induced neurogenic claudication; and symptomatic relief with forward flexion, sitting, or recumbency. Inclusion was also dependent on pre-and posttreatment participation in the Knowledge Program, an institutional prospectively maintained database embedded in our electronic medical record, in which QOL outcomes measures were collected from all patients at each visit. Exclusion criteria included previous spine surgery as well as patients with spinal tumors, cauda equina syndrome, spinal fracture, epilepsy, and renal failure (Table 1) . Education level, median annual household income, and poverty status were calculated based on patients' zip codes (Missouri Census Data Center).
Quality of life
The QOL outcomes questionnaires included the Patient Health Questionnaire-9 (PHQ-9), 20, 27, 28 Pain Disability Questionnaire (PDQ), 12 and EuroQol-5 Dimensions (EQ-5D). 7, 14, 16 For all measures except the EQ-5D, a decrease in score represents improvement. This information has been prospectively collected in the Spine Center since 2009. These data were collected at baseline (before treatment) and at the 4 ± 2-month follow-up.
The PHQ-9 was used to assess for pretreatment depression. This questionnaire is a self-administered assessment for depression in patients that evaluates the 9 Diagnostic and Statistical Manual, ed. IV, criteria for major depressive disorder. Each of the 9 questions is scored from 0 ("not at all") to 3 ("nearly every day"), making the total score range from 0 to 27. The total score is commonly categorized into one of five groups: Minimal (Score 0-4), Mild (Score 5-9), Moderate (Score 10-14), Moderate-Severe (Score 15-19), and Severe (Score 20-27). The PHQ-9 has been validated as a measure of depression in large multicenter analyses. 27, 28 Outcome measures were based on the posttreatment follow-up PDQ and EQ-5D scores. The PDQ evaluates chronic disabling musculoskeletal and spinal disorders, focuses on disability and patients' ability to perform activities of daily living, and ranges from 0 (optimal function) to 150 (total disability). The EQ-5D contains 5 dimensions of the health state, each scored from 1 to 3: Mobility, SelfCare, Usual Activities, Pain/Discomfort, and Anxiety/Depression. The EQ-5D index was derived from the EQ-5D and is defined as a utility value in which perfect health is 1.0 and death is 0.0; anything between perfect health and death is assigned a utility value between 0.0 and 1.0. 7, 15, 16, 19 The QOL data that were obtained were compared with the minimum clinically important differences (MCIDs), which are patient-derived health outcome scores for different QOL measures that reflect the minimum change in QOL necessary to elicit meaningful improvement for the patient. The MCID used for each questionnaire was 16 for the PDQ and 0.1 for the EQ-5D index. 23, 24, 32 
Statistical methods
Summary statistics were computed for all patients using R software, version 2.15.13 (R Core Team, 2013). To examine the association between baseline depression and change in QOL, we created a mixed-effects linear regression model in which 4-month follow-up EQ-5D index or PDQ score was the dependent variable. The independent variable was the pretreatment PHQ-9 score. We adjusted for the following covariates measured at the visit before treatment: baseline EQ-5D index (or PDQ), age, sex, race, body mass index (BMI), insurance status, median household income in US dollars, percent below poverty level, and percent with a bachelor's degree or higher. In addition, a random effect for physician was used to account for correlated responses within a group treated by a single physi- cian. Using these methods, we significantly decreased the possibility of bias and confounding from baseline characteristics. Statistical significance was set at p = 0.05.
results
A total of 502 patients were identified based on inclusion and exclusion criteria. Of these, 490 patients had completed the EQ-5D and 283 had completed the PDQ both before and after treatment. Summary statistics for all patients are provided in Table 2 . The average age was 66.1 years, average BMI was 29.3, 51% (256 of 502) were female, and 90.6% (455 of 502) were white. Table 3 provides a statistical comparison of patients with and without depression as defined by a PHQ-9 score of 10 or higher (depressed). Table 4 displays the pre-and posttreatment QOL scores for all patients. Before treatment, average EQ-5D index improved from 0.61 to 0.68, and average PDQ improved from 65.3 to 60.6. Of the 490 patients who completed the EQ-5D survey pre-and posttreatment, 265 (54.1%) had at least some improvement in EQ-5D index, and 170 (34.7%) had improvement that exceeded the MCID. Of the 283 patients who completed the PDQ both before and after treatment, 152 (53.7%) had at least some improvement and 76 (26.9%) had improvement exceeding the MCID.
After adjusting for the effects of baseline EQ-5D index and patient demographic and clinical variables, there was a significant association between baseline PHQ-9 depression score and 4-month follow-up EQ-5D index (p = 0.0002). For each point higher in baseline PHQ-9 score (worsening depression), the change in EQ-5D index decreased by 0.007 points (95% CI -0.011 to -0.003). This indicates that, with all other things being equal, a patient with a baseline PHQ-9 score of 0 (no depression) would be expected to have a 4-month follow-up EQ-5D index that was 0.14 points higher than a patient with a baseline PHQ-9 score of 20 (severe depression). Figure 1 displays a plot of predicted 4-month follow-up EQ-5D index values across the range of possible baseline PHQ-9 scores for the average patient. These predicted values were calculated by inputting the average values for each continuous variable into the regression equation and by taking weighted averages of the regression coefficients of the categorical variables. When adjusting for the effects of patient demographic and clinical variables, there was no significant association between baseline PHQ-9 score and change in PDQ (b = 0.44, 95% CI -0.26 to 1.14; p = 0.2).
discussion
The incidence of LSS increases throughout life and impacts both daily function and QOL. Surgery is a mainstay treatment, with LSS being the most common reason for lumbar spine surgery in adults older than 65 years. 30 The Spine Patient Outcomes Research Trial (SPORT) as well as other studies revealed that surgery leads to superior pain and function outcomes compared with nonoperative management. 22, 30, 31 The intention-to-treat analysis of SPORT, however, showed no difference between the 2 groups in function and disability, and all analyses revealed no significant worsening with nonsurgical therapy.
6,30 Clinically, many patients prefer conservative treatment or have comorbidities that preclude surgical treatments. Moreover, because surgery is associated with greater cost and complications, it is important to identify both the conservative measures that can improve QOL outcomes and also the patients most likely to benefit from these treatments. A priori identification of patients most likely to improve following spine surgery has been increasingly investigated. Particularly, depression has been shown to be associated with less improvement following lumbar fusion surgery.
1-3,5,9,26,29 There are very few such studies, however, with regard to medical management of LSS. Karp and colleagues 18 reviewed 158 patients who underwent epidural spinal injections for low-back pain with or without radiculopathy. These investigators found that depression and sleep disturbance were prognostic of worse PatientReported Outcome Measurement Information System (PROMIS) outcomes following epidural spinal injections. Hägg et al. 13 performed a randomized controlled trial of 264 patients with severe chronic low-back pain who underwent either surgical or nonsurgical treatment, and assessed the impact of underlying affective disorders. They found that baseline depression correlated with worse outcomes following both operative and nonoperative treatment. Interestingly, they also observed that depressed patients tended to have better outcomes with nonoperative care, whereas nondepressed patients tended to have better outcomes with fusion.
11,13
In the present study, we found that worsening depression (as measured by the PHQ-9) independently significantly predicted worse EQ-5D index outcomes following conservative treatment for LSS (p = 0.0002). This effect was most evident when comparing patients with severe depression, who improve 0.14 points less than those with no depression. This difference exceeds the MCID and confirms that depression is a poor prognostic factor for QOL improvement following nonoperative treatment for LSS. Further investigation is needed to determine whether treatment of depression prior to conservative or surgical management of LSS will improve posttreatment QOL outcomes.
There are several limitations that should be considered when interpreting the results. Multiple treating physicians were included, and factors such as participation in physical therapy, treatment with NSAIDs, opioid medications, and other nonsurgical treatments varied by practitioner and patient; this increases the variability, but also improves the generalizability. We adjusted for the increased variability by using the random effect in the regression models. Many patients were also lost to follow-up at the 4-month evaluation. To assess for bias, Table 5 provides summary statistics comparing the study cohort and the cohort lost to follow-up. The cohorts were similar for most characteristics; however, there were statistically significant, albeit small differences for estimated percent below poverty threshold and median income by zip code. Our analysis is only valid for patients who did follow-up assessments at these time points. Additionally, this was a ret- * Summary statistics for patients in the final cohort identified as depressed (PHQ-9 ≥ 10) or not (PHQ-9 < 10) according to their baseline PHQ-9 score. Results are displayed as the mean ± SD or number (percent) as appropriate.
The p values for continuous variables were obtained using Mann-Whitney U-tests. The Fisher exact test was used for categorical variables. Although the groups were dichotomized for this comparison, for the regression analysis PHQ-9 was used as a continuous score. * Results are displayed as the mean ± SD or number (percent) as appropriate. † Effect (95% CI) of and p values for each 1-unit increase in PHQ-9 score on 4-month follow-up score (EQ-5D index or PDQ total score). Effects have been adjusted for age, BMI, sex, race, marital status, insurance status, % below poverty, % with a bachelor's degree, and baseline EQ-5D index or PDQ total score. rospective study with a relatively short follow-up period. Prospectively designed studies with longer follow-up are needed to further validate the findings. Nonetheless, this is the largest study investigating the correlation between depression and QOL outcomes following conservative management of LSS. We have used the validated PHQ-9 measure of depression 10 and have found a statistically and clinically significant impact on EQ-5D index outcomes.
conclusions
The results of this study suggest that depressed patients with LSS have significantly less improvement following conservative management compared with nondepressed patients. Both physicians and surgeons who treat patients with LSS should consider using validated questionnaires such as the PHQ-9 for pretreatment evaluation of depression, to better assess the likelihood of success following treatment. Further investigation is needed to evaluate the effect of depression treatment prior to management of the spinal disorder. Future prospective studies with longer follow-up intervals may be useful in further evaluating the QOL outcomes in this patient population. 
